Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Finance --- Delivery of Health Care --- Financing, Government. --- Health Care Costs. --- Research Support. --- Medical care --- Medical care, Cost of --- Soins médicaux --- economics. --- Periodicals. --- Finances --- Périodiques --- Coût --- United States. --- Medical care, Cost of. --- Gezondheidszorg. --- Financiering. --- Finance. --- Research Support as Topic. --- Grants and Subsidies, Research --- Subsidies, Research --- Research Subsidies --- Research Subsidy --- Subsidy, Research --- Education --- Costs, Medical Care --- Health Costs --- Healthcare Costs --- Medical Care Costs --- Treatment Costs --- Cost, Health --- Cost, Health Care --- Cost, Healthcare --- Cost, Medical Care --- Cost, Treatment --- Costs, Health --- Costs, Health Care --- Costs, Healthcare --- Costs, Treatment --- Health Care Cost --- Health Cost --- Healthcare Cost --- Medical Care Cost --- Treatment Cost --- Health Expenditures --- Government Financing --- Federal Aid --- Financing, Public --- Grants and Subsidies, Government --- Hill-Burton Act --- Subsidies, Government --- Act, Hill-Burton --- Aid, Federal --- Aids, Federal --- Federal Aids --- Government Subsidies --- Government Subsidy --- Hill Burton Act --- Public Financing --- Subsidy, Government --- Periodicals --- Health Sciences --- Law --- Social Sciences --- Public health --- Insurance Law --- General and Others --- Public Policy & Administration --- Financing, Government --- Health Care Costs --- Research Support as Topic --- economics

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

PART I: Incentives for innovation in the pharmaceutical market - Price regulations systems in the pharmaceutical market - Regulation and competition in pharmaceutical markets - Mechanisms to encourage price competition in the pharmaceutical market and their effects on efficiency and welfare - PART II: Reference pricing as a pharmaceutical reimbursement mechanism - Insurance in public financing of pharmaceuticals - Economic evaluation and pharmaceutical policy - Prescriber incentives - PART III: Economic considerations regarding pharmaceutical expenditure in Spain and its financing - Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanisch economists

Industrial economics --- Public expenditure --- Analysis of pharmaceuticals --- Toxicology --- Pharmaceutical industry --- Drugs --- Government policy --- Finance. --- Research --- Drug Industry --- Financing, Government. --- AA / International- internationaal --- 338.754.12 --- 336.024 --- 368.40 --- financiën, overheid --- geneesmiddelen --- pharmacie --- prijsbeleid --- prijsvorming --- sociale zekerheid --- Government Financing --- Federal Aid --- Financing, Public --- Grants and Subsidies, Government --- Hill-Burton Act --- Subsidies, Government --- Act, Hill-Burton --- Aid, Federal --- Aids, Federal --- Federal Aids --- Government Subsidies --- Government Subsidy --- Hill Burton Act --- Public Financing --- Subsidy, Government --- economics --- Farmaceutische producten en parfumerie. --- Sociale begroting, rekeningen en uitgaven. Gezondheid. --- Sociale voorzorg en verzekeringen. Sociale zekerheid: algemeenheden. --- Financing, Government --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Research&delete& --- Finance --- Sociale begroting, rekeningen en uitgaven. Gezondheid --- Farmaceutische producten en parfumerie --- Sociale voorzorg en verzekeringen. Sociale zekerheid: algemeenheden

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Stem cells --- Federal aid to medical research --- Research --- Moral and ethical aspects --- Government policy --- Finance. --- Stem Cell Research --- Bioethical Issues --- Financing, Government --- Research Support as Topic --- #SBIB:316.334.3M12 --- #SBIB:316.23H2 --- Grants and Subsidies, Research --- Subsidies, Research --- Research Subsidies --- Research Subsidy --- Subsidy, Research --- Education --- Government Financing --- Federal Aid --- Financing, Public --- Grants and Subsidies, Government --- Hill-Burton Act --- Subsidies, Government --- Act, Hill-Burton --- Aid, Federal --- Aids, Federal --- Federal Aids --- Government Subsidies --- Government Subsidy --- Hill Burton Act --- Public Financing --- Subsidy, Government --- Bioethical Issue --- Issue, Bioethical --- Issues, Bioethical --- Euthanasia --- Human Experimentation --- Patient Rights --- Animal Experimentation --- Adult Stem Cell Research --- Embryonic Stem Cell Research --- Research, Stem Cell --- Researchs, Stem Cell --- Stem Cell Researchs --- Stem Cells --- Embryo Research --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Cells --- Medische sociologie: methoden en technieken --- Sociologie van de wetenschappen --- Research&delete& --- Finance

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Financing, Government. --- Health Manpower. --- Medicine. --- Primary Health Care. --- Specialization. --- Physicians --- 364.4 --- Medical care --- -Medical personnel --- -Medical policy --- -Medicine --- -#SBIB:316.334.3M54 --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Health care policy --- Health policy --- Medicine and state --- Policy, Medical --- Public health --- Public health policy --- State and medicine --- Science and state --- Social policy --- Health care personnel --- Health care professionals --- Health manpower --- Health personnel --- Health professions --- Health sciences personnel --- Health services personnel --- Healthcare professionals --- Medical manpower --- Professional employees --- Delivery of health care --- Delivery of medical care --- Health care --- Health care delivery --- Health services --- Healthcare --- Medical and health care industry --- Medical services --- Personal health services --- Specialists --- Specialism --- Specialist --- Primary Healthcare --- Primary Care --- Care, Primary --- Care, Primary Health --- Health Care, Primary --- Healthcare, Primary --- Medical Specialities --- Medical Specialties --- Medical Specialty --- Specialities, Medical --- Specialties, Medical --- Specialty, Medical --- Medical Speciality --- Speciality, Medical --- Health Workforce --- Manpower, Health --- Manpower, Health Occupations --- Health Occupations Manpower --- Workforce, Health --- Health --- Health Occupations --- Health Personnel --- Medicine --- Government Financing --- Federal Aid --- Financing, Public --- Grants and Subsidies, Government --- Hill-Burton Act --- Subsidies, Government --- Act, Hill-Burton --- Aid, Federal --- Aids, Federal --- Federal Aids --- Government Subsidies --- Government Subsidy --- Hill Burton Act --- Public Financing --- Subsidy, Government --- supply & distribution. --- Hulpverlening. Bijstand --- Supply and demand --- -Specialties and specialists --- -Organisatie en financiering van de gezondheidszorg --- Government policy --- manpower --- supply & distribution --- United States. --- Medical personnel --- Medical policy --- Specialties and specialists --- 364.4 Hulpverlening. Bijstand --- Financing, Government --- Health Manpower --- Primary Health Care --- Specialization --- #SBIB:316.334.3M54 --- Organisatie en financiering van de gezondheidszorg --- Access to Primary Care

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"The Chinese economy is now easily one of the most important and closely scrutinized economies in the world. Relatively minuscule changes in predictions of how the Chinese economy will perform can drive up or down stocks and the price of oil and other commodities. At the heart of how the Chinese economy works is its financial system-but the Chinese financial system is vastly different than most people in the West can understand. How do house prices work, for example, in a country where the very concept of property ownership is significantly different than our own? This edited volume will serve as a standard reference guide to China's financial system. With eighteen chapters, the handbook features overviews on the banking sector-the core of China's financial system and the key channel for implementing China's monetary policy-China's ongoing reforms, and the quickly growing bond and money markets, among other topics. Each chapter is written by a leading expert in the field, and as a whole the list of contributors represents an impressive mix of leading scholars and high-level policy officials, some with first-hand knowledge of setting and carrying out Chinese financial policy. The handbook will serve as the first real authoritative volume of literature in the field, and will shed extensive new light on the links between China's financial system and the real economy"--

Finance --- China --- Economic policy --- A-shares. --- British pound. --- C schemes. --- Chinese investment funds. --- Chinese mutual funds. --- Chinese rating agency. --- Euro. --- FDI. --- Fintech cities. --- IFRS. --- IMF. --- IPO reform. --- Japanese yen. --- LGFV. --- McCallum rule. --- PBC policy rates. --- Q schemes. --- QFII. --- RMB cross-border flows. --- RMB internationalization. --- RMB lending. --- RQFII, QDII. --- SOEs. --- Shanghai stock exchange. --- Shenzhen stock exchange. --- Taylor rule. --- US dollar. --- VC. --- accounting system. --- asset management. --- banking institutions. --- banking regulations. --- banking. --- basic social security. --- benchmark rates. --- bond connect. --- bond credit ratings. --- bond markets. --- capital account liberalization. --- central bank independence. --- corporate governance. --- credit extension. --- credit market rates. --- domestic assets. --- employer-sponsored annuity programs. --- equity markets. --- familiarity. --- fintech development. --- fintech regulatory developments. --- fintech. --- foreign direct investment. --- foreign exchange. --- hedge funds. --- infrastructure financing. --- interbank markets. --- interest rate liberalization. --- interest rates. --- internet usage. --- investor behavior. --- investor behavioral biases. --- limited attention. --- liquidity facility rates. --- local government financing vehicles. --- loss aversion. --- macroprudential policies. --- market economy. --- microprudential supervision initiatives. --- monetary policy instruments. --- monetary policy. --- money markets. --- mutual fund industry. --- mutual funds. --- online shopping. --- overconfidence. --- pension system. --- pensions. --- price-based policy instruments. --- private equity funds. --- public pension scheme. --- quantity-based policy instruments. --- real state market. --- representativeness bias. --- shadow banking. --- shareholder activism. --- state-owned commercial banks. --- stock connect. --- stock market regulations. --- stock market. --- venture capital funds. --- venture capital market.